StockData
Impact BioMedical Inc. logo

Impact BioMedical Inc. (IBO) shareholders

IBONYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/30
$3.06+0.38 (+14.18%)

Close on Oct 19, 2026Market cap $329.93MP/E –Yield –

Ownership

Who owns Impact BioMedical's shares

Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 6 sales
Net sold $59.45K

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Frank D. HeuszelChief Executive Officer, Director97,3440.09%Dec 9, 2024
Mark SuseckChief Operating Officer32,1120.03%Nov 5, 2026
Todd D. MackoChief Financial Officer16,4620.02%Nov 5, 2026
Castel Berisford HibbertDirector32,1120.03%Nov 5, 2026
Heng Fai Ambrose ChanDirector, 10% owner32,1120.03%Nov 5, 2026
Jason GradyDirector28,1640.03%Nov 5, 2026
Melissa Kaye SimsDirector32,1120.03%Nov 5, 2026
David K. KeeneDirector32,1120.03%Nov 5, 2026
Christian Thomas ZimmermanDirector32,1120.03%Nov 5, 2026
Elise BrownellDirector32,1120.03%Nov 5, 2026
Dss, Inc.10% owner589,5180.55%Sep 24, 2026
International Ltd Alset10% owner734,0580.68%Apr 4, 2025
Inc. Alset10% owner0–Apr 4, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Mark Suseck
Chief Operating Officer
Oct 7, 2026Award−4,170$4.54$18.93K32,112
Christian Thomas Zimmerman
Director
Oct 7, 2026Award−4,170$4.54$18.93K32,112
Castel Berisford Hibbert
Director
Oct 7, 2026Award−4,170$4.54$18.93K32,112
Melissa Kaye Sims
Director
Oct 7, 2026Award−4,170$4.54$18.93K32,112
David K. Keene
Director
Oct 7, 2026Award−4,170$4.54$18.93K32,112
Elise Brownell
Director
Oct 7, 2026Award−4,170$4.54$18.93K32,112
Heng Fai Ambrose Chan
Director, 10% owner
Oct 7, 2026Award−4,170$4.54$18.93K32,112
Jason Grady
Director
Oct 7, 2026Award−4,170$4.54$18.93K28,164
Todd D. Macko
Chief Financial Officer
Oct 7, 2026Award−4,170$4.54$18.93K16,462
Dss, Inc.
10% owner
Sep 24, 2026Sale−156$7.06$1.10K589,518
Dss, Inc.
10% owner
Sep 23, 2026Sale−27$6.95$188589,674
Dss, Inc.
10% owner
Sep 22, 2026Sale−723$0.55$398589,701
Todd D. Macko
Chief Financial Officer
Mar 27, 2026Sale−43,400$0.56$24.30K155,122
Todd D. Macko
Chief Financial Officer
Mar 25, 2026Sale−1,600$0.60$960198,122
Jason Grady
Director
Mar 23, 2026Sale−50,000$0.65$32.50K250,182
Dss, Inc.
10% owner
May 27, 2025Sale−45,400$0.54$24.52K545,024
Dss, Inc.
10% owner
May 27, 2025Sale−45,400$0.54$24.52K0
Dss, Inc.
10% owner
May 22, 2025Sale−115,600$0.55$63.58K590,424
Dss, Inc.
10% owner
May 22, 2025Sale−115,600$0.55$63.58K45,400
Dss, Inc.
10% owner
Apr 4, 2025Sale−890,800$0.95$846.26K161,100
Inc. Alset
10% owner
Apr 4, 2025Sale−180,000$0.96$172.80K0
Heng Fai Ambrose Chan
Director
Apr 3, 2025Sale−351,555$0.50$175.78K0
Inc. Alset
10% owner
Apr 3, 2025Sale−273,286$0.78$213.16K180,000
Inc. Alset
10% owner
Apr 3, 2025Sale−351,631$0.58$203.95K0
Inc. Alset
10% owner
Apr 2, 2025Sale−382,427$0.58$221.81K351,631
Inc. Alset
10% owner
Apr 2, 2025Sale−2,349$0.67$1.57K351,555
Inc. Alset
10% owner
Apr 2, 2025Sale−200,000$0.67$134.00K353,904
Inc. Alset
10% owner
Apr 2, 2025Sale−300,000$0.58$174.00K553,904
International Ltd Alset
10% owner
Apr 1, 2025Sale−1,176,918$1.08$1.27M734,058
International Ltd Alset
10% owner
Apr 1, 2025Sale−650,000$1.45$942.50K1,910,976
International Ltd Alset
10% owner
Apr 1, 2025Sale−400,000$0.98$392.00K853,904
International Ltd Alset
10% owner
Mar 31, 2025Sale−300,000$1.03$309.00K1,253,904
Dss, Inc.
10% owner
Mar 27, 2025Sale−47,681$2.50$119.20K1,051,800
Dss, Inc.
10% owner
Mar 26, 2025Sale−9,858$3.15$31.05K1,099,481
Dss, Inc.
10% owner
Mar 26, 2025Sale−48,281$3.13$151.12K1,109,339
Dss, Inc.
10% owner
Mar 21, 2025Sale−166,600$3.30$549.78K1,178,882
Dss, Inc.
10% owner
Mar 21, 2025Sale−166,600$3.30$549.78K0
Dss, Inc.
10% owner
Mar 21, 2025Sale−166,600$3.30$549.78K0
Dss, Inc.
10% owner
Mar 20, 2025Buy+200$1.55$31053,280
Dss, Inc.
10% owner
Mar 20, 2025Sale−53,280$4.68$249.35K0
Frank D. Heuszel
Chief Executive Officer, Director
Dec 5, 2024Buy+500$2.26$1.13K97,344
Dss, Inc.
10% owner
Dec 2, 2024Sale−20$2.90$5853,080
Frank D. Heuszel
Chief Executive Officer, Director
Nov 27, 2024Buy+500$2.61$1.31K96,844
Frank D. Heuszel
Chief Executive Officer, Director
Nov 26, 2024Buy+550$2.63$1.45K95,844
Frank D. Heuszel
Chief Executive Officer, Director
Nov 26, 2024Buy+500$2.59$1.30K96,344
Dss, Inc.
10% owner
Nov 18, 2024Sale−5,000$3.02$15.10K53,100
Dss, Inc.
10% owner
Nov 13, 2024Sale−200$2.80$56058,100
Dss, Inc.
10% owner
Nov 12, 2024Sale−500$2.76$1.38K58,300
Dss, Inc.
10% owner
Sep 18, 2024Buy+1,000$2.33$2.33K58,800
Dss, Inc.
10% owner
Sep 17, 2024Buy+7,800$2.40$18.72K57,800
Dss, Inc.
10% owner
Sep 16, 2024Buy+50,000$2.69$134.50K50,000

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
0M shares short
Days to cover
1.1
At 0M shares a day
Change since last report
-6.4%
From 0M shares
Short volume, 20 days
44.6%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Impact BioMedical's stock actually held short. Settlement fails (shares not delivered on time) peaked at 8,465 shares on Sep 18, 2026 over the last 90 days.

See a number that looks wrong?